GlassScriptPhysician profile
Gina Cherry
NPI 1528726205
$1,063.50
in general payments reported to CMS, 2019-2025
19 companies · $64.83 in 2025
The $64.83 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $445 · 2023: $361 · 2024: $192 · 2025: $64.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $178.09 | 2023-2025 | Bavencio |
| Merck Sharp & Dohme LLC | $99.13 | 2022-2024 | Keytruda, Dificid, Prevymis |
| Janssen Biotech, INC. | $77.61 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $76.24 | 2022-2024 | Enhertu |
| Celgene Corporation | $74.28 | 2022 | |
| Amgen INC. | $68.05 | 2022 | |
| Abbvie INC. | $66.79 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.21 | 2022-2023 | Ninlaro |
| Novartis Pharmaceuticals Corporation | $60.95 | 2022-2024 | |
| Sobi, INC | $54.12 | 2022-2024 | |
| Eisai INC. | $51.59 | 2023 | |
| Astellas Pharma US INC | $44.98 | 2022-2023 | Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $27.57 | 2023 | |
| Genzyme Corporation | $24.16 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.34 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $20.59 | 2023 | Libtayo |
| Karyopharm Therapeutics INC. | $19.30 | 2022 | |
| Genentech USA, INC. | $18.08 | 2023 | Tecentriq |
| Grifols USA, LLC | $16.42 | 2023 | Gamunex-C |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gina Cherry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.